Westin Acquisition
WSTNR · NASDAQ
About WSTNR
- Employees
- 2
- Listed
- Nov 4, 2025
- Sector
- N/A
- Industry
- N/A
- Website
- westinacquisitioncorp.com
WSTNR key statistics
- Market cap
- 81.06M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 3.16K
- Volume
- 6.30K
- Open price
- $0.155
- High today
- $0.155
- Low today
- $0.149
- 52 Week high
- $0.22
- 52 Week low
- $0.1501
Westin Acquisition (WSTNR) at a glance
As of Nov 4, 2026, Westin Acquisition (WSTNR) shares are priced at $0.149, giving the company a market cap of 81.06M and a price-to-earnings ratio of 0.00.
Today the stock has traded between $0.149 and $0.155. The current price is 0.0% above the day's low and 3.9% below its high.
Volume so far is 6.30K shares, above the average of 3.16K shares a day.
Over the past year Westin Acquisition has ranged from $0.1501 to $0.22, and now sits -2% of the way up that range.
Most active stocks
Highest trading volume today
- SEIISharing Economy International$0.0002+100.00%
- GPFTGrapefruit USA$0.0002+100.00%
- MASNMaison Luxe$0.0003−40.00%
- HADVHealth Advance$0.0004+100.00%
- SOXLDirexion Shares ETF Trust$66.68−8.81%
- INTCIntel$58.27−3.77%
- CRISCuris$1.11+55.48%
- NVDGraniteShares ETF Trust$4.61+6.47%
- TMGITransglobal Management Group$0.0001+0.00%
- NWGLCL Workshop Group$0.0555−0.36%
- NVDANVIDIA$200.24−3.10%
- BELRBell Rose Capital$0.0002+33.33%
Newly listed
Companies that went public in the past six weeks
- NARANarragansett Bancorp$10.91+0.00%
- ASPEAspen Neuroscience$12.76+3.82%
- BBTXBambusa Therapeutics$16.07+0.44%
- GBCGEORGIA BANKING$34.36+1.06%
- BHAIUBHAV Acquisition Corp II$10.01+0.00%
- SCQCUSPACCircle Acquisition$9.99+0.02%
- LYCALycia Therapeutics$28.92+4.78%
- DAVIDAVION HEALTHCARE$1.67+8.44%
- TCXBTCGX Acquisition Corp. II$10.20+0.99%
- CTYCITY THERAPEUTICS$16.41−14.04%
- IAMIambic Therapeutics$13.40−0.67%
- AMROAmaero$5.33−2.20%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.